Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : PlumCircle, West Mifflin, PA, Etats-Unis
EUR 31,18
Quantité disponible : 1 disponible(s)
Ajouter au panierpaperback. Etat : Very Good. Publisher overstock. May have remainder mark / minor shelfwear. 99% of orders arrive in 4-10 days. Discounted shipping on multiple books.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 51,94
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
EUR 50,74
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 55,16
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : California Books, Miami, FL, Etats-Unis
EUR 58,08
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 51,87
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 51,86
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 58,16
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 81,39
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New.
Edité par LAP LAMBERT Academic Publishing Sep 2020, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 54,90
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Neuware -This is a prospective comparison study between once a day and 3 divided doses of mesalazine in Ulcerative colitis conducted in a tertiary care hospital in Kerala, India. The study was conducted for a period of 18 months from February 2014 to July 2015. The purpose of this study was to find the efficacy and safety between the two different dosing schedules.A total of 60 patients were evaluated of this, 31 patients were in OD treatment group and 29 patients were assigned in the TID group. This study has demonstrated a clinical remission of 61.3% patients in the O.D group and 62.1% in TID. Endoscopic remission was achieved in 71% of patients in O.D group compared to 62.1% in the TID group at the end of 8th week and a Histological remission of 74.2% patients in OD group and 58.6 in the TID group.Patients in O.D group had a significant relief of abdominal pain compared to the TID group (p 0.020). A significant reduction in stool frequency was also seen in OD group (p 0.011).No patients in OD or TID group reported any serious adverse events.Books on Demand GmbH, Überseering 33, 22297 Hamburg 104 pp. Englisch.
Edité par LAP Lambert Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
EUR 56,22
Quantité disponible : Plus de 20 disponibles
Ajouter au panierPAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Edité par LAP Lambert Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
EUR 54,32
Quantité disponible : Plus de 20 disponibles
Ajouter au panierPAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Edité par LAP LAMBERT Academic Publishing Sep 2020, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 54,90
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This is a prospective comparison study between once a day and 3 divided doses of mesalazine in Ulcerative colitis conducted in a tertiary care hospital in Kerala, India. The study was conducted for a period of 18 months from February 2014 to July 2015. The purpose of this study was to find the efficacy and safety between the two different dosing schedules.A total of 60 patients were evaluated of this, 31 patients were in OD treatment group and 29 patients were assigned in the TID group. This study has demonstrated a clinical remission of 61.3% patients in the O.D group and 62.1% in TID. Endoscopic remission was achieved in 71% of patients in O.D group compared to 62.1% in the TID group at the end of 8th week and a Histological remission of 74.2% patients in OD group and 58.6 in the TID group.Patients in O.D group had a significant relief of abdominal pain compared to the TID group (p 0.020). A significant reduction in stool frequency was also seen in OD group (p 0.011).No patients in OD or TID group reported any serious adverse events. 104 pp. Englisch.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : Majestic Books, Hounslow, Royaume-Uni
EUR 84,84
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. Print on Demand.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : moluna, Greven, Allemagne
EUR 45,45
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: SALAM HibaDr. Hiba Salam, born on 14th of January 1988 in Kerala, India. I joined Medical School in 2006 in Karuna Medical College and completed by Internship from Beach Hospital Calicut in 2013. I joined for my Post graduation speci.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
EUR 86,18
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. PRINT ON DEMAND.
Edité par LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6202799390 ISBN 13 : 9786202799393
Langue: anglais
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 55,56
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This is a prospective comparison study between once a day and 3 divided doses of mesalazine in Ulcerative colitis conducted in a tertiary care hospital in Kerala, India. The study was conducted for a period of 18 months from February 2014 to July 2015. The purpose of this study was to find the efficacy and safety between the two different dosing schedules.A total of 60 patients were evaluated of this, 31 patients were in OD treatment group and 29 patients were assigned in the TID group. This study has demonstrated a clinical remission of 61.3% patients in the O.D group and 62.1% in TID. Endoscopic remission was achieved in 71% of patients in O.D group compared to 62.1% in the TID group at the end of 8th week and a Histological remission of 74.2% patients in OD group and 58.6 in the TID group.Patients in O.D group had a significant relief of abdominal pain compared to the TID group (p 0.020). A significant reduction in stool frequency was also seen in OD group (p 0.011).No patients in OD or TID group reported any serious adverse events.